Literature DB >> 25441834

Development and Structural Modifications of Cholinesterase Reactivators against Chemical Warfare Agents in Last Decade: A Review.

Rahul Sharma, Bhanushree Gupta, Namrata Singh, J R Acharya, Kamil Musilek, Kamil Kuca, Kallol Kumar Ghosh1.   

Abstract

Organophosphate (OP) pesticides and nerve agents are responsible for suicidal and accidental poisonings. The acute toxicity of nerve agents leads to progressive inhibition of the enzyme acetylcholinesterase (AChE) by phosphylation of serine residue at the active site of gorge. The recent massive destruction of Syrian civilians by nerve gas sarin, has again renewed the research attention of global science fraternity towards nerve agents, their mode of action and most prominently their therapeutic treatment. This review is principally focused on nerve agent intoxication. The common approach to deal with OP-intoxication is, application of antimuscarinic drug (atropine), anticonvulsant drug (diazepam) and clinically used oximes (pralidoxime, trimedoxime, obidoxime and asoxime). However, the existing therapeutic approach is arguable and has several failings to cure all kinds of nerve agent poisonings. Considering this issue, numerous oximes have been synthesized and screened through various in-vitro and in-vivo studies in last decade to overcome the downsides. At present, only a few oximes (bis pyridinum-oximes) exhibit sound efficacy against selective OPs. In spite of extensive efforts, till date no oxime is available as a universal antidote against all the classes of OPs. This review is centered on the recent developments and structural modification of AChE reactivators against nerve agent toxicity. In particular, a deeper look has been taken into chemical modifications of the reactivators by incorporation of different structural moieties targeted towards the increased reactivation affinity and improved blood brain barrier (BBB) penetration.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25441834     DOI: 10.2174/1389557514666141128102837

Source DB:  PubMed          Journal:  Mini Rev Med Chem        ISSN: 1389-5575            Impact factor:   3.862


  10 in total

1.  Clinical Analysis of Acute Organophosphorus Pesticide Poisoning and Successful Cardiopulmonary Resuscitation: A Case Series.

Authors:  Guangcai Yu; Yaqian Li; Tianzi Jian; Longke Shi; Siqi Cui; Liwen Zhao; Xiangdong Jian; Baotian Kan
Journal:  Front Public Health       Date:  2022-05-27

2.  Docking Studies, Synthesis, and In-vitro Evaluation of Novel Oximes Based on Nitrones as Reactivators of Inhibited Acetylcholinesterase.

Authors:  Seyed Ayoub Hosseini; Abolghasem Moghimi; Maryam Iman; Firoz Ebrahimi
Journal:  Iran J Pharm Res       Date:  2017       Impact factor: 1.696

Review 3.  Organophosphorus compounds and oximes: a critical review.

Authors:  Franz Worek; Horst Thiermann; Timo Wille
Journal:  Arch Toxicol       Date:  2020-06-06       Impact factor: 5.153

4.  The Evaluation of the Reactivating and Neuroprotective Efficacy of Two Newly Prepared Bispyridinium Oximes (K305, K307) in Tabun-Poisoned Rats-A Comparison with Trimedoxime and the Oxime K203.

Authors:  Jiri Kassa; Jan Misik; Jana Hatlapatkova; Jana Zdarova Karasova; Vendula Sepsova; Filip Caisberger; Jaroslav Pejchal
Journal:  Molecules       Date:  2017-07-11       Impact factor: 4.411

5.  Molecular modeling studies on the interactions of 7-methoxytacrine-4-pyridinealdoxime, 4-PA, 2-PAM, and obidoxime with VX-inhibited human acetylcholinesterase: a near attack conformation approach.

Authors:  Jorge Alberto Valle da Silva; Eugenie Nepovimova; Teodorico Castro Ramalho; Kamil Kuca; Tanos Celmar Costa França
Journal:  J Enzyme Inhib Med Chem       Date:  2019-12       Impact factor: 5.051

6.  Synthesis, in vitro screening and molecular docking of isoquinolinium-5-carbaldoximes as acetylcholinesterase and butyrylcholinesterase reactivators.

Authors:  David Malinak; Rafael Dolezal; Vendula Hepnarova; Miroslava Hozova; Rudolf Andrys; Petr Bzonek; Veronika Racakova; Jan Korabecny; Lukas Gorecki; Eva Mezeiova; Miroslav Psotka; Daniel Jun; Kamil Kuca; Kamil Musilek
Journal:  J Enzyme Inhib Med Chem       Date:  2020-12       Impact factor: 5.051

7.  Influence of Experimental End Point on the Therapeutic Efficacy of Essential and Additional Antidotes in Organophosphorus Nerve Agent-Intoxicated Mice.

Authors:  Jiri Kassa; Christopher M Timperley; Mike Bird; A Christopher Green; John E H Tattersall
Journal:  Toxics       Date:  2022-04-15

8.  TRPA1 channel mediates organophosphate-induced delayed neuropathy.

Authors:  Qiang Ding; Sui Fang; Xueqin Chen; Youxin Wang; Jian Li; Fuyun Tian; Xiang Xu; Bernard Attali; Xin Xie; Zhaobing Gao
Journal:  Cell Discov       Date:  2017-08-01       Impact factor: 10.849

Review 9.  Trends in the Recent Patent Literature on Cholinesterase Reactivators (2016-2019).

Authors:  Alexandre A de Castro; Letícia C Assis; Flávia V Soares; Kamil Kuca; Daniel A Polisel; Elaine F F da Cunha; Teodorico C Ramalho
Journal:  Biomolecules       Date:  2020-03-12

10.  Reactivation of VX-Inhibited Human Acetylcholinesterase by Deprotonated Pralidoxime. A Complementary Quantum Mechanical Study.

Authors:  Jorge Alberto Valle da Silva; Ander Francisco Pereira; Steven R LaPlante; Kamil Kuca; Teodorico Castro Ramalho; Tanos Celmar Costa França
Journal:  Biomolecules       Date:  2020-01-27
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.